Annual Shareholders Equity
$100.98 M
-$8.24 M-7.54%
December 31, 2023
Summary
- As of February 7, 2025, YMAB annual stockholders equity is $100.98 million, with the most recent change of -$8.24 million (-7.54%) on December 31, 2023.
- During the last 3 years, YMAB annual shareholders equity has fallen by -$4.85 million (-4.58%).
- YMAB annual shareholders equity is now -49.23% below its all-time high of $198.90 million, reached on December 31, 2019.
Performance
YMAB Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$92.43 M
-$2.91 M-3.05%
September 30, 2024
Summary
- As of February 7, 2025, YMAB quarterly stockholders equity is $92.43 million, with the most recent change of -$2.91 million (-3.05%) on September 30, 2024.
- Over the past year, YMAB quarterly shareholders equity has dropped by -$8.56 million (-8.47%).
- YMAB quarterly shareholders equity is now -63.35% below its all-time high of $252.22 million, reached on March 31, 2021.
Performance
YMAB Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
YMAB Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.5% | -8.5% |
| 3 y3 years | -4.6% | -15.4% |
| 5 y5 years | -28.1% | -15.4% |
YMAB Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -43.9% | at low | -48.7% | at low |
| 5 y | 5-year | -49.2% | at low | -63.4% | at low |
| alltime | all time | -49.2% | +737.3% | -63.4% | +41.1% |
Y-mAbs Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $92.43 M(-3.0%) |
| Jun 2024 | - | $95.34 M(-3.9%) |
| Mar 2024 | - | $99.19 M(-1.8%) |
| Dec 2023 | $100.98 M(-7.5%) | $100.98 M(+0.8%) |
| Sep 2023 | - | $100.15 M(-4.3%) |
| Jun 2023 | - | $104.68 M(-2.9%) |
| Mar 2023 | - | $107.83 M(-1.3%) |
| Dec 2022 | $109.22 M(-39.4%) | $109.22 M(+1.2%) |
| Sep 2022 | - | $107.90 M(-17.9%) |
| Jun 2022 | - | $131.40 M(-16.6%) |
| Mar 2022 | - | $157.47 M(-12.6%) |
| Dec 2021 | $180.11 M | $180.11 M(-14.6%) |
| Sep 2021 | - | $210.84 M(-10.0%) |
| Jun 2021 | - | $234.32 M(-7.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $252.22 M(+138.3%) |
| Dec 2020 | $105.84 M(-46.8%) | $105.84 M(-9.2%) |
| Sep 2020 | - | $116.51 M(-20.2%) |
| Jun 2020 | - | $146.01 M(-16.7%) |
| Mar 2020 | - | $175.33 M(-11.9%) |
| Dec 2019 | $198.90 M(+41.5%) | $198.90 M(+131.4%) |
| Sep 2019 | - | $85.94 M(-20.7%) |
| Jun 2019 | - | $108.38 M(-13.6%) |
| Mar 2019 | - | $125.51 M(-10.7%) |
| Dec 2018 | $140.53 M(+71.1%) | $140.53 M(-9.4%) |
| Sep 2018 | - | $155.03 M(+136.6%) |
| Jun 2018 | - | $65.52 M(-20.2%) |
| Dec 2017 | $82.15 M(+581.1%) | $82.15 M |
| Dec 2016 | $12.06 M | - |
FAQ
- What is Y-mAbs Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics annual shareholders equity year-on-year change?
- What is Y-mAbs Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics quarterly shareholders equity year-on-year change?
What is Y-mAbs Therapeutics annual stockholders equity?
The current annual shareholders equity of YMAB is $100.98 M
What is the all time high annual shareholders equity for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high annual stockholders equity is $198.90 M
What is Y-mAbs Therapeutics annual shareholders equity year-on-year change?
Over the past year, YMAB annual stockholders equity has changed by -$8.24 M (-7.54%)
What is Y-mAbs Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of YMAB is $92.43 M
What is the all time high quarterly shareholders equity for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high quarterly stockholders equity is $252.22 M
What is Y-mAbs Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, YMAB quarterly stockholders equity has changed by -$8.56 M (-8.47%)